lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
287 rows where filing_period = "second_quarter", filing_year = 2021 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2632549 | 4C COMMUNICATIONS, INC. c03c74ec-8196-46c1-a043-70cb0ec13da6 | Q2 | 4C COMMUNICATIONS, INC. | 323717 | HEALTHCARE LEADERSHIP COUNCIL | 2021 | second_quarter | PHA | The Treat Act | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-07-02T11:57:23.323000-04:00 | ||
| 2632559 | PENN AVENUE PARTNERS 3ce8fd8d-8939-41e6-a9d8-ee4aed14bb7f | Q2 | PENN AVENUE PARTNERS | 400918672 | ALKERMES, INC. | 2021 | second_quarter | PHA | Regulatory and legislative issues impacting Alkermes. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-02T12:47:30.710000-04:00 | |
| 2633071 | STONINGTON GLOBAL f8c293a9-3cec-4c86-babd-e55028a78712 | Q2 | STONINGTON GLOBAL | 401105189 | SORRENTO THERAPEUTICS, INC. | 2021 | second_quarter | PHA | Regulatory approvals and funding for pharmaceutical products and devices | Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 130000 | 0 | 0 | 2021-07-06T13:17:21.127000-04:00 | |
| 2633848 | PENN AVENUE PARTNERS 7c5ac628-ce96-4601-bd38-9fec094a62d0 | Q2 | PENN AVENUE PARTNERS | 400918672 | UNITEDHEALTH GROUP, INC. | 2021 | second_quarter | PHA | Pharmacy benefit related issues. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 90000 | 0 | 0 | 2021-07-07T17:47:08.467000-04:00 | |
| 2633948 | AMERICAN COLLEGE OF CLINICAL PHARMACY c73ff5b5-3718-401f-b944-79b0cd238fdc | Q2 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2021 | second_quarter | PHA | Coverage for direct patient care services of qualified clinical pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2021-07-08T09:10:46.310000-04:00 | |
| 2634068 | WATKINS & EAGER PLLC 4fae6076-de3c-40f0-b42c-b762bb5ed069 | Q2 | WATKINS & EAGER PLLC | 401104403 | ZYNERBA PHARMACEUTICALS, INC. | 2021 | second_quarter | PHA | Providing services on behalf of Zynerba to the pharmaceutical industry | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2021-07-08T11:18:35.717000-04:00 | |
| 2634673 | INDEPENDENT PHARMACY COOPERATIVE b53db0a4-0d71-4208-bbe9-14010b33015e | Q2 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2021 | second_quarter | PHA | IPC supports S. 1909/H.R. 3554, the Pharmacy DIR Reform to Reduce Senior Drug Costs Act. Support regulations/laws that would eliminate pharmacy DIR. IPC supports Pharmacists as Providers under Medicare Part B. IPC supports Pharmacy and Medically Underserved Areas Enhancement Act, H.R. 2759/S. 1362 IPC supports Pharmacists as Immunizers IPC supports 340B Program and contract pharmacies IPC supports Federal Retail Pharmacy COVID-19 Vaccination Program expansion. | Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 30000 | 0 | 0 | 2021-07-09T13:41:25.140000-04:00 | |
| 2634708 | 340B HEALTH 1743993d-d55b-47d0-9173-e07325a21413 | Q2 | 340B HEALTH | 316434 | 340B HEALTH | 2021 | second_quarter | PHA | The 340B Drug Pricing Program; S.773 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R. 853: Closing Loopholes for Orphan Drugs Act; H.R.3203 - To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R.19 - Lower Costs, More Cures Act of 2021; | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 272268 | 0 | 0 | 2021-07-09T14:42:00.983000-04:00 | |
| 2634854 | BUCHANAN INGERSOLL & ROONEY PC 6e91c212-04f3-4999-a98a-3b55bf3d7fe7 | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | GALEPHAR PHARMACEUTICAL RESEARCH INC. | 2021 | second_quarter | PHA | Strategy development and implementation of federal government relations initiatives relating to the Food and Drug Administrations Pre-Approval of Supplemental through New Drug Application (NDA). | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-07-10T07:10:54.357000-04:00 | |
| 2634855 | BUCHANAN INGERSOLL & ROONEY PC af5951c7-ed6d-482f-a200-1c8fde5f9c6d | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | OHEMO LIFE SCIENCES INC. | 2021 | second_quarter | PHA | Strategy development and implementation of federal government relations initiatives relating to the Food and Drug Administrations Pre-Approval of Supplemental through New Drug Application (NDA). | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-07-10T07:13:55.763000-04:00 | |
| 2634860 | BUCHANAN INGERSOLL & ROONEY PC b74668fc-880d-4f22-8ce7-cae67bc2124f | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | GENERIC ANIMAL DRUG ALLIANCE | 2021 | second_quarter | PHA | Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-07-10T07:15:57.160000-04:00 | |
| 2635050 | PANNONE LOPES DEVEREAUX & O'GARA LLC 5dbab130-0fbd-4032-aa13-0517058bf97c | Q2 | PANNONE LOPES DEVEREAUX & O'GARA LLC | 401105501 | AMGEN | 2021 | second_quarter | PHA | Prescription drug pricing. | 9000 | 0 | 0 | 2021-07-12T09:09:55.760000-04:00 | ||
| 2635081 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES cdc9d2c4-beb6-4535-8521-9f28b0a543b8 | Q2 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2021 | second_quarter | PHA | Interfaced with the White House, Operation Warp Speed; HHS Secretary and team, and CDC to drive COVID testing & vaccinations across the nation. H.R. 1002 Debarment Enforcement of Bad Actor Registrants Act H.R. 1899 Ensuring Compliance Against Drug Diversion Act | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 260000 | 0 | 0 | 2021-07-12T10:46:29.487000-04:00 | |
| 2635115 | BUCHANAN INGERSOLL & ROONEY PC 484293c9-494f-4a01-acd1-f34e63b2c482 | Q2 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | AIM IMMUNOTECH INC. | 2021 | second_quarter | PHA | Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. FY 2022 Appropriations for Defense Department, and National Institutes of Health (NIH) | Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Navy, Dept of,SENATE | 40000 | 0 | 0 | 2021-07-12T11:27:08.793000-04:00 | |
| 2635144 | LUPIN PHARMACEUTICALS INC 1321c831-c121-462f-824c-40955827b58c | Q2 | LUPIN PHARMACEUTICALS INC | 401104766 | LUPIN PHARMACEUTICALS INC | 2021 | second_quarter | PHA | None | HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR) | 202049 | 0 | 0 | 2021-07-12T11:53:37.030000-04:00 | |
| 2635302 | CRISPR THERAPEUTICS, INC. 7ea4b772-4387-4eaf-970e-f026bea3358d | Q2 | CRISPR THERAPEUTICS, INC. | 401105184 | CRISPR THERAPEUTICS, INC. | 2021 | second_quarter | PHA | Coverage & reimbursement for Cell and Gene Therapies | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2021-07-12T13:52:29.563000-04:00 | |
| 2635427 | POLSINELLI PC 3939410d-c15a-473e-9e2c-e0630bd619ed | Q2 | POLSINELLI PC | 314911 | TEVA PHARMACEUTICALS USA, INC. | 2021 | second_quarter | PHA | Issues related to pricing, reimbursement, and manufacturing of pharmaceutical products Review of Administration telehealth policies | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-07-12T15:32:17.040000-04:00 | |
| 2635857 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION 067f0c87-268a-4a1e-8845-3689399904d7 | Q2 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | 401103605 | PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION | 2021 | second_quarter | PHA | COVID-19 vaccine & therapeutic production, and pandemic protection. Pharmaceutical supply chain and domestic manufacturing | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-13T11:33:23.487000-04:00 | |
| 2635913 | RED+BLUE STRATEGIES 3d300760-1db8-4e02-8b4e-baf5b1473ab7 | Q2 | RED+BLUE STRATEGIES | 400693064 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2021 | second_quarter | PHA | PL 117-2 - The American Rescue Plan Act Implementation - Issues related to policies focused on increasing access to health care coverage, including access to prescription drugs, for Americans with both public and private insurance. Issues related to Trump-era rules and regulations regarding Medicare rebate policies and PBM transparency. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2021-07-13T12:25:58.407000-04:00 | |
| 2635920 | RED+BLUE STRATEGIES f834780d-9852-4c10-a098-f9713189b91e | Q2 | RED+BLUE STRATEGIES | 400693064 | PEW CHARITABLE TRUSTS | 2021 | second_quarter | PHA | PL 117-2 - The American Rescue Plan Act Implementation - Issues related to the increased substance use disorder crisis in America, the need for a more robust pipeline for antibiotics to protect the nation, a more coherent HIT system to ensure robust public data and other related public health issues. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 963 - Mainstreaming Addiction Treatment Act (The MAT Act) - Supporting access to MAT to help avoid opioid-related deaths in the country. S. 2076 - The Pioneering Antimicrobial Subscriptions to End Surging Resistance Act ( PASTEUR Act) - Issues related to improving the antibiotic pipeline to address antimicrobial resistance. Issues related to ensuring clear information regarding the safety of supplements. Issues related to dealing with antimicrobial resistance among the US population. | HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 60000 | 0 | 0 | 2021-07-13T12:40:00.663000-04:00 | |
| 2635958 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2e407914-87cb-4d4b-8eb3-378cdcc59dd9 | Q2 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2021 | second_quarter | PHA | OTC switch process -- no bill number Cures 2.0 -- no bill number | Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of | 189000 | 0 | 0 | 2021-07-13T13:11:09.680000-04:00 | |
| 2636349 | MARSHALL & POPP, LLC b5a756ce-587a-4541-9981-7ebcf905a2ee | Q2 | MARSHALL & POPP, LLC | 401105121 | GENENTECH, INC. | 2021 | second_quarter | PHA | Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act. Issues related to supply chains, 340B, and the COVID-19 pandemic. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-13T17:21:09.987000-04:00 | |
| 2636400 | MARSHALL & POPP, LLC 57d25686-cb63-43c5-8555-5b1afb85bed1 | Q2 | MARSHALL & POPP, LLC | 401105121 | PFIZER, INC. | 2021 | second_quarter | PHA | Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-07-13T17:31:16.673000-04:00 | |
| 2636406 | MARSHALL & POPP, LLC 3b5262a0-3de6-46fe-aa52-0bd5157a906f | Q2 | MARSHALL & POPP, LLC | 401105121 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2021 | second_quarter | PHA | Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-07-13T17:35:18.060000-04:00 | |
| 2636409 | MARSHALL & POPP, LLC 99e043e9-f666-4333-a4e0-32bbb1487b63 | Q2 | MARSHALL & POPP, LLC | 401105121 | SANOFI U.S. SERVICES, INC. | 2021 | second_quarter | PHA | Issues related to prescription drug value, including H.R.3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 22/S.2164, the Lower Costs, More Cures Act. Issues related to vaccine development and distribution. Issues related to supply chains, 340B, and the COVID-19 pandemic. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-13T17:37:18.737000-04:00 | |
| 2636497 | HANCE SCARBOROUGH 43f75837-b11a-4a4a-8679-bd89269121fa | Q2 | HANCE SCARBOROUGH | 17443 | PHRMA | 2021 | second_quarter | PHA | Patent reform regarding pharmaceutical research & products. | SENATE | 30000 | 0 | 0 | 2021-07-14T00:09:45.030000-04:00 | |
| 2636752 | WAXMAN STRATEGIES 7bdb3a53-5a69-49a1-bc1f-44c808655aa3 | Q2 | WAXMAN STRATEGIES | 401103693 | 340B HEALTH | 2021 | second_quarter | PHA | Issues affecting the 340B drug pricing program; Appropriations for 340B program. | HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2021-07-14T11:44:52.397000-04:00 | |
| 2636857 | FARRAGUT PARTNERS LLP d9a0b958-e99f-4e44-aba0-355e29136903 | Q2 | FARRAGUT PARTNERS LLP | 401103938 | COMMUNITY ONCOLOGY ALLIANCE | 2021 | second_quarter | PHA | Issues related to pharmacy benefit managers. HR 3258 TACT Act | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-07-14T12:43:22.297000-04:00 | |
| 2636948 | FARRAGUT PARTNERS LLP 3af014f0-dd08-4145-b9d0-2367ba6b93f9 | Q2 | FARRAGUT PARTNERS LLP | 401103938 | ONEONCOLOGY INC. | 2021 | second_quarter | PHA | Issues related to pharmacy benefit managers. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-14T13:27:50.200000-04:00 | |
| 2637414 | BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC 88a4b57c-d2f7-40d0-998f-7eb3c22b59ae | Q2 | BRAEBURN INC. FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC | 401104621 | BRAEBURN INC FORMERLY KNOWN AS BRAEBURN PHARMACEUTICALS INC | 2021 | second_quarter | PHA | HR 1629, S250 Fairness in Orphan Drug Exclusivity Act; Administration of controlled substances by HCPs; Storage of controlled substances | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE | 110000 | 0 | 0 | 2021-07-14T20:17:17.333000-04:00 | |
| 2637507 | ACG ADVOCACY 3de8514a-e6ae-45ca-9632-9d3d4ae55519 | Q2 | ACG ADVOCACY | 2057 | BAYER CROPSCIENCE LP | 2021 | second_quarter | PHA | Medication disposal. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-15T08:50:47.670000-04:00 | |
| 2637553 | RUBICON ADVISORS, LLC 31326ac8-1646-4210-8600-6f1064482272 | Q2 | RUBICON ADVISORS, LLC | 315091 | DYNAVAX TECHNOLOGIES | 2021 | second_quarter | PHA | Prescription Drug User Fee, Biomedical Advance Research and Development Authority (BARDA) | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2021-07-15T09:37:00.263000-04:00 | |
| 2637554 | RUBICON ADVISORS, LLC bf18b12e-53d5-423a-93ef-4e540d6c7ebf | Q2 | RUBICON ADVISORS, LLC | 315091 | DR. REDDY'S LABORATORIES, LTD | 2021 | second_quarter | PHA | Prescription Drug User Fee (PDUFA) re authorization.Generic Drug User Fee Act (GDUFA) re authorization. Border Adjustment Tax(BAT)issues | Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 60000 | 0 | 0 | 2021-07-15T09:39:00.760000-04:00 | |
| 2637556 | RUBICON ADVISORS, LLC c6546c0c-f03f-44f8-b965-32c834c93015 | Q2 | RUBICON ADVISORS, LLC | 315091 | CONSCIOUS DISCIPLINE | 2021 | second_quarter | PHA | Medicare | HOUSE OF REPRESENTATIVES,SENATE | 67500 | 0 | 0 | 2021-07-15T09:40:01.693000-04:00 | |
| 2637558 | RUBICON ADVISORS, LLC 0229e5e9-9861-4d18-9bb1-386225aef5e1 | Q2 | RUBICON ADVISORS, LLC | 315091 | LANNETT COMPANY, INC | 2021 | second_quarter | PHA | Medicare and Medicaid, Generic Prescription, COVID-19 Stimulus | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 50000 | 0 | 0 | 2021-07-15T09:42:02.610000-04:00 | |
| 2637559 | RUBICON ADVISORS, LLC d76c0b24-4d4a-4009-867c-d6658c06a9ec | Q2 | RUBICON ADVISORS, LLC | 315091 | AVET PHARMACEUTICALS | 2021 | second_quarter | PHA | GENERIC DRUG PRICING,HOUSE COMMITTEE ON OVERSIGHT,GOVERNMENT REFORM, FOOD AND DRUG ADMINISTRATION AND COVID-19 DRUG SHORTAGES | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2021-07-15T09:44:03.077000-04:00 | |
| 2637562 | ACADEMY OF MANAGED CARE PHARMACY a5d584dc-7af9-464c-8fea-9f644de4dce3 | Q2 | ACADEMY OF MANAGED CARE PHARMACY | 48793 | ACADEMY OF MANAGED CARE PHARMACY | 2021 | second_quarter | PHA | Cures 2.0 - This bill is in discussion draft form. Lobbying on issues in bill related to medication adherence, caregiver training, pre-approval information exchange, cell and gene therapies, digital therapeutics, and confirmatory studies for accelerated approval drugs. Pre-approval information exchange - lobbying for the introduction of a bill to codify FDA guidance creating a safe harbor for the practice of pre-approval information exchange between drug manufacturers and health plans. S.1909/HR. 3554 - A bill relating to direct and indirect remuneration in Medicare Part D. S. 1362 - Pharmacy and Medically Underserved Areas Enhancement Act - to provide for coverage under the Medicare program of pharmacist services | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-15T09:45:04.193000-04:00 | |
| 2637567 | RUBICON ADVISORS, LLC dfe8876c-d138-4627-9231-0efe74a86b8e | Q2 | RUBICON ADVISORS, LLC | 315091 | ASCENDIS PHARMA, INC. | 2021 | second_quarter | PHA | Food and Drug Administration, Orphan Drugs | Food & Drug Administration (FDA) | 60000 | 0 | 0 | 2021-07-15T09:52:06.123000-04:00 | |
| 2637809 | BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. 54c331f9-1c41-4fc9-af25-db797c5482b9 | Q2 | BLUE CROSS AND BLUE SHIELD OF KANSAS, INC. | 323876 | BLUE CROSS AND BLUE SHIELD OF KANSAS INC | 2021 | second_quarter | PHA | COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx reform; Prescription drugs; Prescription Drug Reform; H.R. 3 - Lower Drug Costs Now Act Sponsor: Rep. Frank Pallone (D-NJ-06) H.R. 2831 - Prompt Approval of Safe Generic Drugs Act Sponsor: Rep. Nanette Barragan (D-CA-44) | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-07-15T12:20:28.920000-04:00 | |
| 2637857 | KNIGHT CAPITOL CONSULTANTS 1252405d-0ca0-4879-8bc2-caa1f91446f1 | Q2 | KNIGHT CAPITOL CONSULTANTS | 40036301 | EQUASHIELD, LLC | 2021 | second_quarter | PHA | Provisions affecting vial reuse being discussed in connection with drug pricing legislation (no specific bills) | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-07-15T12:52:47.987000-04:00 | |
| 2638156 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 47849297-beac-4e64-86f8-73d02404b3ef | Q2 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 27478 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2021 | second_quarter | PHA | S. 298 / H.R. 1829, the Pharmacy Benefit Manager Accountability Study Act of 2021; H.R. 3655, the Vaccine Injury Compensation Modernization Act of 2021; H.R. 3656, the Vaccine Access Improvement Act of 2021; H.R. 3662, the Patient Access to Urgent-Use Pharmacy Compounding Act of 2021; COVID vaccine distribution | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA),White House Office | 370000 | 0 | 0 | 2021-07-15T14:21:25.210000-04:00 | |
| 2638326 | RED+BLUE STRATEGIES 3eb566f6-32ba-45b5-98bd-2653619b6878 | Q2 | RED+BLUE STRATEGIES | 400693064 | COHERUS BIOSCIENCES | 2021 | second_quarter | PHA | S. 164 - Biosimilars Education Act of 2021 - A bill to raise awareness of the efficacy and promise of biosimilars in the American health care system. Issues and policies that incent companies to increase their US footprint and adopt Made in America business practices. Policies to help grow the biosimilars marketplace in the United States. Policies focused on improving cancer care through access to affordable treatments. | HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 60000 | 0 | 0 | 2021-07-15T15:04:59.790000-04:00 | |
| 2638582 | HANCE SCARBOROUGH ba62e432-e669-4d5b-8889-17c9ccc0982c | Q2 | HANCE SCARBOROUGH | 17443 | BOEHRINGER INGELHEIM USA CORPORATION | 2021 | second_quarter | PHA | Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-07-15T16:02:09.783000-04:00 | |
| 2638713 | NELSON MULLINS RILEY & SCARBOROUGH 83ad9312-9648-4d1a-bc64-aecec4b42470 | Q2 | NELSON MULLINS RILEY & SCARBOROUGH | 285871 | HEMOPHILIA OF GEORGIA | 2021 | second_quarter | PHA | 340B Drug Pricing Program, Medicare, biomedical research, ACA implementation and COVID-19 response and relief legislation | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-07-15T17:55:46.587000-04:00 | |
| 2638986 | PUBLIC CITIZEN 8f59bb4d-36cf-4daa-9fee-52c321e56a60 | Q2 | PUBLIC CITIZEN | 32362 | PUBLIC CITIZEN | 2021 | second_quarter | PHA | Covid-19 Vaccine Manufacturing and access and related funding, drug price negotiation, FAIR drug pricing Act, clinical trial cost transparency, HR 3 Lower drug prices now act, HR 2096-SACKLER Act, Affordable medications act, prescription drug price spike remedies, Medical Innovation act, National Biomedical research act, USTR access to medicines position, HR 3778/S 1976 (NOVID act), Aducanumab, S.1435-Affordable Prescriptions for Patients act, | Consumer Product Safety Commission (CPSC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Occupational Safety & Health Administration (OSHA),Securities & Exchange Commission (SEC),SENATE,Treasury, Dept of,White House Office | 150000 | 0 | 0 | 2021-07-16T08:31:35.043000-04:00 | |
| 2639167 | BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. b5a06b17-fb87-43e7-a14a-507afd417824 | Q2 | BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. | 6382 | BLUE CROSS AND BLUE SHIELD OF FLORIDA INC | 2021 | second_quarter | PHA | COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx Reform; Prescription Drugs; Prescription Drug Reform HR 3 (117th Congress), Elijah E. Cummings Lower Drug Costs Now Act, by Rep. Frank Pallone (D-NJ). Establishes a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees. HR 550 (117th Congress), Immunization Infrastructure Modernization Act of 2021, by Rep. Ann Kuster (D-NH). Amends the Public Health Service Act with respect to immunization system data modernization and expansion. HR 951 (117th Congress), Maternal Vaccination Act, by Rep. Terri Sewell (D-AL). Directs the Secretary of Health and Human Services to carry out a national campaign to increase awareness of the importance of maternal vaccinations for the health of pregnant and postpartum individuals and their children. HR 979 (117th Congress), Vaccine Fairness Act, by Rep. Angie Craig (D-MN). Directs the Secretary of Health and Human Services to submit to Congress a weekly report on COVID-19 vaccine distribution. HR 1452 (117th Congress), by Rep. Dan Crenshaw (R-TX). Directs the Secretary of Health and Human Services to publish the formula the Secretary uses to determine the allocation of COVID-19 vaccines. HR 1978 (117th Congress), Protecting Seniors Through Immunization Act of 2021, by Rep. Ann Kuster (D-NH). Amends title XVIII of the Social Security Act to provide information regarding vaccines for seniors as part of the Medicare & You handbook and to ensure that the treatment of cost sharing for vaccines under Medicare Part D is consistent with the treatment of vaccines under Medicare Part B. HR 2347 (117th Congress), Strengthening the Vaccines for Children Program Act of 2021, by Rep. Kim Schrier (D- WA). Amends title XIX of the Social Security Act to ensure adequate access to vaccines under the Medicaid program and the Vaccines for Children program. HR 2831 (117th Congress), Prompt Approval of Safe Ge… | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,White House Office | 150000 | 0 | 0 | 2021-07-16T10:11:25.923000-04:00 | |
| 2639185 | GUIDEWELL MUTUAL HOLDING CORPORATION 6e199a11-d153-407e-b541-08b2a212cf35 | Q2 | GUIDEWELL MUTUAL HOLDING CORPORATION | 401103191 | GUIDEWELL MUTUAL HOLDING CORPORATION | 2021 | second_quarter | PHA | COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx Reform; Prescription Drugs; Prescription Drug Reform HR 3 (117th Congress), Elijah E. Cummings Lower Drug Costs Now Act, by Rep. Frank Pallone (D-NJ). Establishes a fair price negotiation program, protect the Medicare program from excessive price increases, and establish an out-of-pocket maximum for Medicare part D enrollees. HR 550 (117th Congress), Immunization Infrastructure Modernization Act of 2021, by Rep. Ann Kuster (D-NH). Amends the Public Health Service Act with respect to immunization system data modernization and expansion. HR 951 (117th Congress), Maternal Vaccination Act, by Rep. Terri Sewell (D-AL). Directs the Secretary of Health and Human Services to carry out a national campaign to increase awareness of the importance of maternal vaccinations for the health of pregnant and postpartum individuals and their children. HR 979 (117th Congress), Vaccine Fairness Act, by Rep. Angie Craig (D-MN). Directs the Secretary of Health and Human Services to submit to Congress a weekly report on COVID-19 vaccine distribution. HR 1452 (117th Congress), by Rep. Dan Crenshaw (R-TX). Directs the Secretary of Health and Human Services to publish the formula the Secretary uses to determine the allocation of COVID-19 vaccines. HR 1978 (117th Congress), Protecting Seniors Through Immunization Act of 2021, by Rep. Ann Kuster (D-NH). Amends title XVIII of the Social Security Act to provide information regarding vaccines for seniors as part of the Medicare & You handbook and to ensure that the treatment of cost sharing for vaccines under Medicare Part D is consistent with the treatment of vaccines under Medicare Part B. HR 2347 (117th Congress), Strengthening the Vaccines for Children Program Act of 2021, by Rep. Kim Schrier (D- WA). Amends title XIX of the Social Security Act to ensure adequate access to vaccines under the Medicaid program and the Vaccines for Children program. HR 2831 (117th Congress), Prompt Approval of Safe Ge… | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 0 | 0 | 2021-07-16T10:16:32.493000-04:00 | ||
| 2639361 | BROWN & FORTUNATO, P.C. 83c41352-7527-44a2-8df5-db93784ddf6b | Q2 | BROWN & FORTUNATO, P.C. | 401104878 | PROMPTCARE COMPANIES, INC. | 2021 | second_quarter | PHA | Issues related to Medicare home infusion therapy benefit and other health care issues. Issues related to the Medicare DMEPOS competitive bidding program and Medicare coverage and payment for non-invasive ventilators. | Centers For Medicare and Medicaid Services (CMS) | 20000 | 0 | 0 | 2021-07-16T10:52:10.090000-04:00 | |
| 2639655 | KOUNTOUPES DENHAM CARR & REID, LLC 171d882f-aebf-4027-a334-b5afdb3d3f46 | Q2 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | GLENMARK PHARMACEUTICALS, INC., USA | 2021 | second_quarter | PHA | Issues related to the implementation of H.R. 1319, the American Rescue Plan. Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-16T11:58:29.223000-04:00 | |
| 2639771 | AMERICAN VETERINARY MEDICAL ASSOCIATION 2b0327da-cd15-45e0-94a6-56e63de90593 | Q2 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 3630 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 2021 | second_quarter | PHA | Prescription Mandate Legislation Draft Compounding Guidance (GFI 256) H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S. 1698 Hemp Access and Consumer Safety Act (Mark) | Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 220000 | 0 | 0 | 2021-07-16T12:20:52.393000-04:00 | |
| 2640168 | AARP f61a6f6d-a6c0-49cf-b666-b5d3906b0436 | 2A | AARP | 1694 | AARP | 2021 | second_quarter | PHA | No bill number. Discussed prescription drugs and Medicare. No bill number - FY 2022 Agriculture, Rural Development & FDA Appropriations. | Administration for Children & Families (ACF),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Consumer Financial Protection Bureau (CFPB),Corporation for Natl & Community Service,Defense, Dept of (DOD),Equal Employment Opportunity Commission (EEOC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Natl Transportation Safety Board (NTSB),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Comptroller of the Currency (OCC),Pension Benefit Guaranty Corporation (PBGC),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,Veterans Affairs, Dept of (VA),White House Office | 2720000 | 0 | 0 | 2021-07-16T13:47:26.323000-04:00 | |
| 2640191 | HANCE SCARBOROUGH 1d6e9316-2e8a-4790-a86a-d59b412ead57 | Q2 | HANCE SCARBOROUGH | 17443 | ALLIANCE FOR PHARMACY COMPOUNDING | 2021 | second_quarter | PHA | Issues related to the regulation of pharmacy compounding. Issues related to preserving patient access to compounded medications. Fiscal Year 2022 Appropriations | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-16T13:48:27.723000-04:00 | |
| 2640269 | FLYNN & ASSOCIATES, INC. a8e85ca9-e28e-4ebb-a931-a1fdaee05f64 | Q2 | FLYNN & ASSOCIATES, INC. | 15020 | PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION | 2021 | second_quarter | PHA | H.R. 3 - Price controls for prescription drugs. Importation of drugs from other countries. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-16T14:06:47.567000-04:00 | |
| 2640375 | LINCOLN PARK GROUP L.L.C. ca2c3809-4156-41e0-93f2-e246f9b17b50 | Q2 | LINCOLN PARK GROUP L.L.C. | 401104374 | CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2021 | second_quarter | PHA | Support for S. 920/H.R. 2181 - A bill to amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals and S. 259/H.R. 832 - Safe and Affordable Drugs from Canada Act; issues related to personal drug importation. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-07-16T14:36:12.057000-04:00 | |
| 2640599 | KOUNTOUPES DENHAM CARR & REID, LLC 4477ae4b-f7e3-4756-9021-7c8281533333 | Q2 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2021 | second_quarter | PHA | General issues related to over the counter pharmaceuticals, pharmaceutical supply chain and country of origin labeling, including S.1260, United States Innovation and Competition Act of 2021. Implementation of the Over the Counter Monograph provisions included in PL 116-136, Coronavirus Aid, Relief and Economic Security Act. Issues related to supplements. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-16T15:21:20.090000-04:00 | |
| 2640717 | UNITED FOOD & COMMERCIAL WORKERS INTERNATIONAL UNION 7a55d00c-8a21-4524-8595-98cd4edd1465 | Q2 | UNITED FOOD & COMMERCIAL WORKERS INTERNATIONAL UNION | 39121 | UNITED FOOD & COMMERCIAL WORKERS INTERNATIONAL UNION | 2021 | second_quarter | PHA | Met with Senate staff regarding prescription drug reform. | HOUSE OF REPRESENTATIVES,SENATE | 190000 | 0 | 0 | 2021-07-16T15:44:46.520000-04:00 | |
| 2640905 | FORBES-TATE 5d894fd8-2b21-4fc2-b362-b9d5d38fb1f8 | Q2 | FORBES-TATE | 400976792 | CALIFORNIA LIFE SCIENCES ASSOCIATION | 2021 | second_quarter | PHA | Issues related to the life sciences industry; Issues related to drug pricing and international reference pricing. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-16T16:23:35.373000-04:00 | |
| 2640977 | BROYDRICK & ASSOCIATES 049dbb77-da45-4623-af23-5f21842fb989 | Q2 | BROYDRICK & ASSOCIATES | 7268 | EXELA PHARMA SCIENCES | 2021 | second_quarter | PHA | Drug shortages and FDA approval, USTR acceptance. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-07-16T16:35:57.020000-04:00 | ||
| 2641048 | BROYDRICK & ASSOCIATES a0c67346-44bd-4fa8-b294-a5affa70fc4c | Q2 | BROYDRICK & ASSOCIATES | 7268 | TONIX PHARMACEUTICALS | 2021 | second_quarter | PHA | Funding new drug for PTSD and COVID 19. | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-07-16T16:48:24.467000-04:00 | |
| 2641049 | SIMS STRATEGIES, LLC 4065651e-1e35-4abb-9e2b-dc6677f61c50 | Q2 | SIMS STRATEGIES, LLC | 401104546 | AMAG PHARMACEUTICAL | 2021 | second_quarter | PHA | Pharmaceutical issues related to womens health product access. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-07-16T16:48:24.930000-04:00 | |
| 2641234 | FORBES-TATE 776eae36-0434-4205-980b-9a3259a23910 | Q2 | FORBES-TATE | 400976792 | MERCK | 2021 | second_quarter | PHA | Issues related to prescription drug pricing, vaccines, animal health, and maternal health. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-16T17:22:15.677000-04:00 | |
| 2641297 | FOLEY & LARDNER LLP b35eb576-d7b2-4224-a94e-3edd445c5fbc | Q2 | FOLEY & LARDNER LLP | 15042 | BLINK HEALTH LTD (A BERMUDA LIMITED COMPANY) | 2021 | second_quarter | PHA | Market-based solutions to drug pricing and chain pharmacy barriers to generic pharmaceutical price reduction. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-16T17:41:31.253000-04:00 | |
| 2641586 | REPUBLIC CONSULTING, LLC 401fd9e9-8164-4011-ab93-153f22cbe072 | Q2 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2021 | second_quarter | PHA | Monitored Health Data Policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-17T09:41:27.690000-04:00 | |
| 2641670 | FORBES-TATE ea16dba0-542f-49bf-aaad-877acd74b862 | Q2 | FORBES-TATE | 400976792 | PHRMA | 2021 | second_quarter | PHA | Issues pertaining to prescription drug pricing. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-07-17T10:41:06.520000-04:00 | |
| 2642114 | BROWNSTEIN HYATT FARBER SCHRECK, LLP 29cbeb88-4060-4fed-aa45-772d4057c895 | Q2 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 7257 | AKTIV PHARMA GROUP | 2021 | second_quarter | PHA | Supply chain issues related to production of pharmaceuticals | SENATE | 20000 | 0 | 0 | 2021-07-17T14:37:04.297000-04:00 | |
| 2642160 | THE KUTLER GROUP 6053acee-e313-40cb-8a70-f82c9e89efcb | Q2 | THE KUTLER GROUP | 401103966 | PRIME THERAPEUTICS | 2021 | second_quarter | PHA | drug pricing issues | HOUSE OF REPRESENTATIVES,SENATE | 24000 | 0 | 0 | 2021-07-17T15:01:19.390000-04:00 | |
| 2642223 | CAPITOL COUNSEL LLC c6676808-7b2e-41b1-8138-f8f18a874722 | Q2 | CAPITOL COUNSEL LLC | 313715 | EMD SERONO, INC. | 2021 | second_quarter | PHA | Monitoring and engaging on health policy proposals coming before the House of Representatives and the Administration pertaining to the availability and pricing of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-17T15:21:38.317000-04:00 | |
| 2642394 | FORBES-TATE 3f6ee994-509c-4069-8db8-c2fe86ffa001 | Q2 | FORBES-TATE | 400976792 | INDEPENDENT PHARMACY COOPERATIVE | 2021 | second_quarter | PHA | Issues related to pharmacy regulation, the MAC Transparency Act, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-17T16:35:30.723000-04:00 | |
| 2642628 | KNIGHT CAPITOL CONSULTANTS 445214e9-2d51-42b8-b5c0-c239a80ce9e7 | 2A | KNIGHT CAPITOL CONSULTANTS | 40036301 | REGENXBIO | 2021 | second_quarter | PHA | Possible legislation which may affect Food and Drug Administration review of biologic products (no specific bill) | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-17T21:44:39.107000-04:00 | |
| 2642643 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 3a55754e-9fb8-4c68-b20c-1b389ddd46d3 | Q2 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 35968 | SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021 | second_quarter | PHA | Compounding, preparation, packaging and dispensing of radiopharmaceuticals | Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE | 52000 | 0 | 0 | 2021-07-17T21:58:42.947000-04:00 | |
| 2643277 | FORBES-TATE 2063e0e5-7dc1-46b0-b6cf-ee2b75f6d915 | Q2 | FORBES-TATE | 400976792 | VERDE TECHNOLOGIES | 2021 | second_quarter | PHA | Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-07-18T15:17:38.590000-04:00 | |
| 2643413 | E3 STRATEGIC CONSULTING GROUP 65710229-de48-4b49-bce3-a728f0026e2d | Q2 | E3 STRATEGIC CONSULTING GROUP | 401104104 | HEINZ STRATEGIES LLC (ON BEHALF OF PILMA) | 2021 | second_quarter | PHA | Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 3, Elijah E. Cummings Lower Drug Costs Now Act. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-07-18T16:32:17.750000-04:00 | |
| 2643414 | E3 STRATEGIC CONSULTING GROUP 79b8b412-37a9-4907-a842-c35433b02a77 | Q2 | E3 STRATEGIC CONSULTING GROUP | 401104104 | PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION | 2021 | second_quarter | PHA | Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally; HR 3, Elijah E. Cummings Lower Drug Costs Now Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-07-18T16:33:18.220000-04:00 | |
| 2643497 | POLARIS GOVERNMENT RELATIONS, LLC 3c5518be-c173-4bbd-9e1e-b6975c6c3ef4 | Q2 | POLARIS GOVERNMENT RELATIONS, LLC | 307730 | CIGNA CORPORATION | 2021 | second_quarter | PHA | Issues related to drug pricing, generally | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2021-07-18T17:06:43.220000-04:00 | |
| 2643778 | TARPLIN, DOWNS & YOUNG, LLC 58933e38-8441-4745-a82d-55e841f13ab7 | Q2 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | ASTRAZENECA | 2021 | second_quarter | PHA | Drug coverage & reimbursement vaccination no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-07-18T20:23:14.283000-04:00 | |
| 2643808 | TARPLIN, DOWNS & YOUNG, LLC 02866f7c-ebd8-4e5e-9808-db7f3eac131a | Q2 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2021 | second_quarter | PHA | H.R. 1319, American Rescue Plan of 2021 no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, patent settlements, break through therapies, Innovation, transparency no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, Innovation | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2021-07-18T20:41:21.610000-04:00 | |
| 2644042 | VAN SCOYOC ASSOCIATES 65579070-a332-4916-a928-7bf0706bfee8 | Q2 | VAN SCOYOC ASSOCIATES | 39837 | ZEBRA TECHNOLOGIES CORP. | 2021 | second_quarter | PHA | Temperature monitoring technology for COVID-19 vaccines, Domestic and International distribution related issues Temperature monitoring technology, generally | SENATE | 30000 | 0 | 0 | 2021-07-19T07:01:21.787000-04:00 | |
| 2644339 | ELI LILLY AND COMPANY be8f4150-18e0-4fc7-b53c-f93607e4df24 | Q2 | ELI LILLY AND COMPANY | 13392 | ELI LILLY AND COMPANY | 2021 | second_quarter | PHA | Hospital discounts; 340B program | Commerce, Dept of (DOC),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 1675000 | 0 | 0 | 2021-07-19T09:07:34.960000-04:00 | |
| 2644561 | M.J. SIMON & COMPANY, LLC a9d4ecb7-391a-4001-9e26-7f0a5f35b60c | Q2 | M.J. SIMON & COMPANY, LLC | 40026223 | NOBELPHARMA AMERICA | 2021 | second_quarter | PHA | FDA inspections | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2021-07-19T09:44:21.133000-04:00 | ||
| 2644597 | TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES) bb283776-a866-4bf8-87c7-02de865d100b | Q2 | TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES) | 90250 | AMAG PHARMACEUTICAL | 2021 | second_quarter | PHA | Pharmaceutical issues; access to women's health pharmaceutical products. | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2021-07-19T09:48:28.113000-04:00 | |
| 2644937 | MOVEON.ORG CIVIC ACTION 0b9b428d-c9dc-4dbb-8f75-8a90a56b72eb | Q2 | MOVEON.ORG CIVIC ACTION | 401106098 | MOVEON.ORG CIVIC ACTION | 2021 | second_quarter | PHA | HR 3, Elijah E. Cummings Lower Drug Costs Now Act; S 898, Fair Accountability and Innovative Research Drug Pricing Act of 2021 | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-07-19T10:38:44.127000-04:00 | |
| 2645332 | CHRISTOPHER HEINZ 6b016906-7ad7-49d4-89e5-db5352bf3ac9 | Q2 | CHRISTOPHER HEINZ | 318298 | PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION | 2021 | second_quarter | PHA | Prescription drug industry issues relating to domestic construction and maintenance employment and all other issues affecting employment in the industry, generally. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2021-07-19T11:16:08.523000-04:00 | |
| 2645456 | KOUNTOUPES DENHAM CARR & REID, LLC 715b36a1-42db-43d4-b137-06f95b134b3f | Q2 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | CVS HEALTH | 2021 | second_quarter | PHA | General education about the pharmacy benefit manager/pharmacy and insurance industry. Issues related to drug pricing. Issues related to the drug supply chain. Issues related to the implementation of H.R. 133, Consolidated Appropriations Act for Fiscal Year 2021. Issues related to the implementation of H.R. 1319, The American Rescue Plan, including provisions related to vaccine distribution. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-19T11:28:39.737000-04:00 | |
| 2645679 | LUNGREN LOPINA LLC f0f10825-50d4-441a-af7d-e6763a712f65 | Q2 | LUNGREN LOPINA LLC | 401103314 | AMPAC FINE CHEMICALS | 2021 | second_quarter | PHA | Fair treatment for US based pharmaceutical ingredients | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-07-19T11:50:34.520000-04:00 | |
| 2645984 | BROWNSTEIN HYATT FARBER SCHRECK, LLP 41e6017c-e185-40ed-8662-2794d1367d33 | Q2 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 7257 | WALGREEN CO. | 2021 | second_quarter | PHA | Pharmacist provider status, Pharmacy benefits on military bases, Issues related to COVID-19 relief H.R.1319 - American Rescue Plan Act of 2021 | HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS) | 60000 | 0 | 0 | 2021-07-19T12:17:40.427000-04:00 | |
| 2646160 | KOUNTOUPES DENHAM CARR & REID, LLC e8fbf3a0-225d-4db5-933b-8a3a9b3588e8 | Q2 | KOUNTOUPES DENHAM CARR & REID, LLC | 320918 | BLOOD CANCER UNITED (FORMERLY REPORTED ASTHE LEUKEMIA AND LYMPHOMA SOCIETY) | 2021 | second_quarter | PHA | Issues related to the cost of care and protecting patient access to blood cancer treatment. Issues related to specialty drug tiers. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 50000 | 0 | 0 | 2021-07-19T12:36:20.180000-04:00 | |
| 2646199 | THORSEN FRENCH ADVOCACY LLC 331ea68b-2029-4799-a620-6f4446477a91 | Q2 | THORSEN FRENCH ADVOCACY LLC | 400599826 | HEALTHCARE DISTRIBUTION ALLIANCE | 2021 | second_quarter | PHA | Issues related to regulation of prescription opioid medication. Issues related to vaccine distribution. H.R.133: Consolidated Appropriations Act, 2021. H.R.786: Supporting State and Local Leaders Act. H.R.768: Block, Report, And Suspend Suspicious Shipments Act of 2021. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-07-19T12:40:30.660000-04:00 | |
| 2646207 | FOLEY & LARDNER LLP 133024d4-768c-492c-bed6-675d44e0bef5 | Q2 | FOLEY & LARDNER LLP | 15042 | ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY | 2021 | second_quarter | PHA | FDA issues; Issues relating to prescription drug abuse; Issues relating to CDC guidance for prescribing opioids; Issues relating to removal of FDA unapproved products from the market. | HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2021-07-19T12:41:32.600000-04:00 | |
| 2646289 | THORSEN FRENCH ADVOCACY LLC 1a7e0d23-9588-469b-a9fb-df615739807a | Q2 | THORSEN FRENCH ADVOCACY LLC | 400599826 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2021 | second_quarter | PHA | Issues related to pharmaceutical market value. Global supply chain. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2021-07-19T12:49:56.397000-04:00 | |
| 2646418 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER 4534f03a-238e-4a2a-a057-e56f2ca91f47 | Q2 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2021 | second_quarter | PHA | 340B | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 32870 | 0 | 0 | 2021-07-19T13:03:27.927000-04:00 | |
| 2646749 | SUMMIT PUBLIC AFFAIRS e75e60d9-1d19-4db5-b238-c8a266c6db1f | Q2 | SUMMIT PUBLIC AFFAIRS | 401105467 | VANDA PHARMACEUTICALS INC. | 2021 | second_quarter | PHA | Issues affecting the pharmaceutical industry, including the prescription drug approval process, animal testing, and gastroparesis issues. Implementation of the American Rescue Plan Act of 2021 (Pub. L. No. 117-7). 21st Century Cures Act 2.0 (proposed legislation). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2021-07-19T13:45:44.917000-04:00 | |
| 2646792 | TARPLIN, DOWNS & YOUNG, LLC c1247a24-8f46-4d4c-9d83-7a946fdab839 | 2A | TARPLIN, DOWNS & YOUNG, LLC | 304736 | ASTRAZENECA | 2021 | second_quarter | PHA | Drug coverage & reimbursement vaccination no specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-07-19T13:48:53.687000-04:00 | |
| 2646957 | TARPLIN, DOWNS & YOUNG, LLC 7fcfa42e-7a57-4e0e-bf45-d7c0f7791c80 | 2A | TARPLIN, DOWNS & YOUNG, LLC | 304736 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2021 | second_quarter | PHA | H.R. 1319, American Rescue Plan of 2021 implementation no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, patent settlements, break through therapies, Innovation, transparency no specific bills, Drug Safety, Prescription Drug Importation, Import Safety, supply chain integrity, biosimilars, PDUFA and associated policies, patent settlements, accelerated approval, break through therapies, compounding, user fee reauthorization, Innovation | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2021-07-19T14:05:28.917000-04:00 | |
| 2647246 | GOVERNMENT COUNSEL, LLC b100644f-f822-42d6-aceb-3ba023d970ba | Q2 | GOVERNMENT COUNSEL, LLC | 401105070 | HEALTHCARE DISTRIBUTION ALLIANCE | 2021 | second_quarter | PHA | H.R. 768-Block, Report, And Suspend Suspicious Shipments Act of 2021; General issues relating to implementation of Public Law 113-54 (DSCSA;Pandemic Vaccine Tracking Improvement Act Discussion Draft. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2021-07-19T14:25:27.810000-04:00 | |
| 2647648 | TARPLIN, DOWNS & YOUNG, LLC feb66008-6093-4d35-83ab-1fd59a58e1df | Q2 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2021 | second_quarter | PHA | Opioid Abuse - General issues related to opioid abuse (implementation of Public Law 115-271) Issues related to ARCOS data and suspicious order record requirements and reporting (HR 768) Importation of Prescription Drugs (HR 832, HR 2181, S 259, S 920, Public Law 108-173) Implementation of Public Law 113-54 (DSCSA) | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2021-07-19T14:57:05.963000-04:00 | |
| 2647784 | ISEMAN & ASSOCIATES LLC a3f4e0cb-2d1c-45eb-8802-b2ae40aeddd2 | Q2 | ISEMAN & ASSOCIATES LLC | 401103582 | TICHENOR VENTURES, LLC | 2021 | second_quarter | PHA | Monitoring biotech legislation; prescription drug prices | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2021-07-19T15:06:36.883000-04:00 | |
| 2648235 | NATIONAL ASSOCIATION OF SPINE SPECIALISTS 79b788b5-90ab-4b1b-8fb4-4d7efd1cf07d | Q2 | NATIONAL ASSOCIATION OF SPINE SPECIALISTS | 400395865 | NATIONAL ASSOCIATION OF SPINE SPECIALISTS | 2021 | second_quarter | PHA | H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act Issue: Requested clarification on certain key provisions reducing patients' access to medically-necessary treatments. | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 60000 | 0 | 0 | 2021-07-19T15:38:21.937000-04:00 | |
| 2648301 | THERMO FISHER SCIENTIFIC INC. e9aaa50d-96ad-4e23-9280-fad3b45cc608 | Q2 | THERMO FISHER SCIENTIFIC INC. | 323251 | THERMO FISHER SCIENTIFIC INC | 2021 | second_quarter | PHA | Worker training program. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Food & Drug Administration (FDA),General Services Administration (GSA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT) | 1020000 | 0 | 0 | 2021-07-19T15:42:35.600000-04:00 | |
| 2648684 | NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS c6c07931-e4f6-4c73-84cf-6ec9792a288b | Q2 | NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS | 26808 | NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS | 2021 | second_quarter | PHA | H.R. 3 (Elijah E. Cummings Lower Drug Costs Now Act): This bill establishes several programs and requirements relating to the prices of prescription drugs. H.R. 19 (Lower Costs, More Cures Act of 2021): To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, the Food and Drug Administration, and for other purposes. H.R. 3775 (State-Based Universal Health Care Act of 2021): To amend title I of the Patient Protection and Affordable Care Act to authorize the establishment of, and provide support for, State-based universal health care systems that provide comprehensive health benefits to State residents, and for other purposes. S. 1180 (Choose Medicare Act): Would establish a Medicare Part E that individuals and employers can opt into. H.R. 1319 (American Rescue Plan Act): To provide for reconciliation pursuant to title II of S. Con. Res. 5. S. 1180: Choose Medicare Act: Would establish a Medicare Part E that individuals and employers can opt into. H.R. 1868 (Medicare Sequester): Extends a suspension of Medicare sequestration and make other technical changes to Medicare payments and Medicaid eligibility. | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),SENATE,Treasury, Dept of,White House Office | 330000 | 0 | 0 | 2021-07-19T16:07:00.123000-04:00 | |
| 2648709 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 9d88a5c3-b0f8-4aca-a67e-a16e727a34ac | Q2 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2021 | second_quarter | PHA | Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, implementation of the Drug Quality and Security Act. Conversation with DEA regulation on Medication-Assisted Treatment and drug shortages. Discussed COVID-19 response recommendations with House and Senate Offices, White House Offices, and HHS and its subagencies, and DEA. Contact HHS, House and Senate Offices concerning rule enforcement of the 340B Drug Pricing Program. Contact FDA concerning the practice of White Bagging and Brown Bagging patient medications. | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 320000 | 0 | 0 | 2021-07-19T16:09:07.197000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);